Zusammenfassung
Unter pränatalem Screening werden Untersuchungen während der Schwangerschaft verstanden, durch die Hinweise auf das Vorliegen einer bestimmten schweren Krankheit oder Behinderung des Kindes gegeben werden können.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Brand IR, Kaminopetros P, Mairead C, Irving HC, Lilford RJ (1994) Specificity of antenatal ultrasound in the Yorkshire region: a prospective study of 2261 ultrasound detected anomalies. Br J Obstet Gynaecol 101: 392–397
Brock DJH (1992) Alphafetoprotein and acetylcholinesterase. In: Brock DJH, Rodeck CH, Ferguson-Smith MA (eds) Prenatal diagnosis and screening. Churchill Livingstone, Edinburgh, pp 159–168
Chitty LS (1995) Ultrasonound screening for fetal abnormalities. Prenat Diagn 15: 1241–1257
Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K (2001) Absence of nasal bone in fetuses with trisomy 21 at 11—14 weeks of gestation: an observational study. Lancet 358: 1665–1667
Cuckle HS, Wald NJ (1993) Complementary use of biochemical tests and ultrasonography for detection of neural tube defects and Down’s syndrome: Diagnosis. In: Chervenak FA, Isaacson GC, Campbell S (eds) Ultrasound in obstetrics and gynecology. Little, Brown, Boston, pp 1145–1150
Cuckle HS, Wald NJ, Thompson SG (1987) Estimating a woman’s risk of having a pregnancy associated with Down’s syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387–402
Cuckle H, Nanchahal K, Wald N (1991) Birth prevalence of Down’s syndrome in England and Wales. Prenat Diagn 11: 29–34
DiGuiseppi C (1996) Screening ultrasonography in pregnancy. Guide to clinical preventive services. National Library of Medicine, Health Services/ technology assessment text, http://text.nlm.nih.gov/cps/www/cps.42.html.
Eskes TKAB (1994) Possible basis for primary prevention of birth defects with folic acid. Fetal Diagn Ther 9: 149–154
Eurocat (1995) Surveillance of congenital anomalies in Europe 1980-1992. Institute of Hygiene and Epidemiology, Brussels
Evans Ml, Chik L, O’Brien JE, et al. (1995) MOMs (multiples of the median) and DAD’s (discriminant aneupoloidy detection): Improved specificity and cost-effectiveness of biochemical screening for aneuploidy with DADs. Am J Obstet Gynecol 172: 1138–1149
Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D (1993) Effect of prenatal ultrasound screening on perinatal outcome. RADIUS Study Group. N Engl J Med 329: 821–827
Götzmann L, Schönholzer SM, Kölble N et al. (2002) Die Ultraschall-Untersuchung bei Verdacht auf fetale Entwicklungsstörungen: Zufriedenheit und Bewertungen aus Sicht der betroffenen Frauen. Ultraschall Med (in print)
Greene NDE, Copp AJ (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nature Med 3: 60–66
Hook EB (1992) Prevalence, risks and recurrence. In: Brock DJH, Rodeck CH, Ferguson-Smith MA (eds) Prenatal diagnosis and screening. Churchill Livingstone, Edinburgh, pp 351–392
Huether CA, Gummere GR, Hook EB et al. (1981) Down’s syndrome: percentage reporting on birth certificates and single year maternal age risk rates for Ohio 1970-79: comparison with upstate New York data. Am J Public Health 71: 1367–1372
Kürzt R (1993) Diagnostische Ergebnisse und ihre klinische Interpretation — oder: Was Sie schon immer über Diagnostik nicht wissen wollten. Geburtsh Frauenheilk 53: 15–19
Neilson JP (1995) Routine ultrasound in early pregnancy. In Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP (eds) Pregnancy and childbirth module of the Cochrane database of systematic reviews. BMJ Publishing Group, London, updated 24 February
Nicolaides KH, Snijders RJM, Gosden CM, Berry C, Campbell S (1992) Ultrasonographically detectable markers of fetal chromosomal abnormalities. Lancet 340: 704–707
Nicolaides KH, Sebire NJ, Snijders RJM (1999) The 11–14 week scan. Parthenon, London
Nørgaard-Pedersen B, Larsen SO, Arends J, Svenstrup B, Tabor A (1990) Maternal serum markers in screening for Down’s syndrome. Clin Genet 37: 35–43
Palomaki GE, Haddow JE (1987) Maternal serum alpha-fetoprotein, age, and Down’s syndrome risk. Am J Obstet Gynecol 156: 460–463
Pilu G, Nicolaides KH (1999) Diagnosis of fetal abnormalities: the 18–23 week scan. Parthenon, London
Reynolds TM, Penney MD (1989) The mathematical basis of multivariate risk screening: with special reference to screening for Down’s syndrome associated pregnancy. Ann Clin Biochem 27: 452–458
Saridogan E, Djahanbakhch O, Naftalin AA (1996) Screening for Down’s syndrome: experience in an inner city health district. Br J Obstet Gynaecol 103: 1205–1211
Shackley P, McGuire A, Boyd PA, Dennis J, Fitchett M, Kay J, Roche M, Wood P (1993) An economic appraisal of alternative pre-natal screening programmes for Down’s syndrome. J Publ Health Med 15: 175–184
Wald NJ (1984) Antenatal and neonatal screening. Oxford University Press, p 32
Wald NJ, Cuckle HS, Densem JW et al. (1988) Maternal serum screening for Down’s syndrome in early pregnancy. BMJ 297: 883–887
Wald NJ, Watt HC, Hackshaw AK (1999) Integrated screening for Down’s syndrome on the basis of tests performed during the first and second trimesters. N Engl J Med 341: 461–467
Wigglesworth JS (1991) Causes and classification of fetal and perinatal death. In: Wigglesworth JS, Singer DB (eds) Textbook of fetal and perinatal pathology. Blackwell, Boston, pp 77–91
Williamson P, Alberman E, Rodeck C, Fiddler M, Church S, Harris R (1997) Antecedent circumstances surrounding neural tube defect births in 1990-91. Br J Obstet Gynaecol 104: 51–56
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Zimmermann, R. (2004). Screening auf Fehlbildungen und Chromosomenstörungen. In: Schneider, H., Husslein, P., Schneider, KT.M. (eds) Die Geburtshilfe. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18574-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-18574-8_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-30522-4
Online ISBN: 978-3-642-18574-8
eBook Packages: Springer Book Archive